GAROFALO HEALTH CARE SPA (GHC.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:GHC - IT0005345233 - Common Stock
5.5 EUR
-0.05 (-0.9%)
GHC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 30 industry peers in the Health Care Providers & Services industry. GHC has only an average score on both its financial health and profitability. GHC has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- In the past year GHC was profitable.
- In the past year GHC had a positive cash flow from operations.
- In the past 5 years GHC has always been profitable.
- Each year in the past 5 years GHC had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 3.66%, GHC is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
- GHC has a Return On Equity (9.57%) which is in line with its industry peers.
- GHC's Return On Invested Capital of 6.52% is fine compared to the rest of the industry. GHC outperforms 66.67% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for GHC is below the industry average of 6.46%.
- The 3 year average ROIC (4.41%) for GHC is below the current ROIC(6.52%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.66% | ||
| ROE | 9.57% | ||
| ROIC | 6.52% |
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
1.3 Margins
- GHC has a Profit Margin of 4.62%. This is in the better half of the industry: GHC outperforms 80.00% of its industry peers.
- In the last couple of years the Profit Margin of GHC has declined.
- GHC's Operating Margin of 9.37% is amongst the best of the industry. GHC outperforms 83.33% of its industry peers.
- GHC's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 44.90%, GHC is in the better half of the industry, outperforming 63.33% of the companies in the same industry.
- GHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.37% | ||
| PM (TTM) | 4.62% | ||
| GM | 44.9% |
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GHC is destroying value.
- GHC has about the same amout of shares outstanding than it did 1 year ago.
- GHC has more shares outstanding than it did 5 years ago.
- GHC has a better debt/assets ratio than last year.
2.2 Solvency
- GHC has an Altman-Z score of 1.97. This is not the best score and indicates that GHC is in the grey zone with still only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 1.97, GHC is in line with its industry, outperforming 46.67% of the companies in the same industry.
- The Debt to FCF ratio of GHC is 70.49, which is on the high side as it means it would take GHC, 70.49 years of fcf income to pay off all of its debts.
- With a Debt to FCF ratio value of 70.49, GHC is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
- A Debt/Equity ratio of 0.67 indicates that GHC is somewhat dependend on debt financing.
- GHC has a Debt to Equity ratio of 0.67. This is in the better half of the industry: GHC outperforms 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 70.49 | ||
| Altman-Z | 1.97 |
ROIC/WACC0.99
WACC6.58%
2.3 Liquidity
- GHC has a Current Ratio of 1.16. This is a normal value and indicates that GHC is financially healthy and should not expect problems in meeting its short term obligations.
- With a decent Current ratio value of 1.16, GHC is doing good in the industry, outperforming 63.33% of the companies in the same industry.
- A Quick Ratio of 1.12 indicates that GHC should not have too much problems paying its short term obligations.
- GHC's Quick ratio of 1.12 is fine compared to the rest of the industry. GHC outperforms 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
- GHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.11%.
- GHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.81% yearly.
- GHC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.44%.
- GHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.92% yearly.
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
3.2 Future
- Based on estimates for the next years, GHC will show a small growth in Earnings Per Share. The EPS will grow by 6.47% on average per year.
- The Revenue is expected to grow by 1.51% on average over the next years.
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 15.28 indicates a correct valuation of GHC.
- Compared to the rest of the industry, the Price/Earnings ratio of GHC indicates a somewhat cheap valuation: GHC is cheaper than 66.67% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.38. GHC is valued slightly cheaper when compared to this.
- Based on the Price/Forward Earnings ratio of 17.02, the valuation of GHC can be described as rather expensive.
- The rest of the industry has a similar Price/Forward Earnings ratio as GHC.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.29, GHC is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.28 | ||
| Fwd PE | 17.02 |
4.2 Price Multiples
- GHC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GHC is cheaper than 83.33% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of GHC indicates a slightly more expensive valuation: GHC is more expensive than 73.33% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 152.74 | ||
| EV/EBITDA | 7.58 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The decent profitability rating of GHC may justify a higher PE ratio.
PEG (NY)4.43
PEG (5Y)1.73
EPS Next 2Y5.05%
EPS Next 3Y6.47%
5. Dividend
5.1 Amount
- GHC has a Yearly Dividend Yield of 1.57%. Purely for dividend investing, there may be better candidates out there.
- GHC's Dividend Yield is comparable with the industry average which is at 1.73.
- GHC's Dividend Yield is comparable with the S&P500 average which is at 1.84.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.57% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y5.05%
EPS Next 3Y6.47%
BIT:GHC (1/19/2026, 7:00:00 PM)
5.5
-0.05 (-0.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-14 2025-11-14
Earnings (Next)N/A N/A
Inst Owners11.85%
Inst Owner ChangeN/A
Ins Owners63%
Ins Owner ChangeN/A
Market Cap496.10M
Revenue(TTM)690.85M
Net Income(TTM)31.91M
Analysts84
Price Target6.73 (22.36%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.57% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.28 | ||
| Fwd PE | 17.02 | ||
| P/S | 0.72 | ||
| P/FCF | 152.74 | ||
| P/OCF | 17.76 | ||
| P/B | 1.49 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.58 |
EPS(TTM)0.36
EY6.55%
EPS(NY)0.32
Fwd EY5.88%
FCF(TTM)0.04
FCFY0.65%
OCF(TTM)0.31
OCFY5.63%
SpS7.66
BVpS3.7
TBVpS-0.44
PEG (NY)4.43
PEG (5Y)1.73
Graham Number5.47
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.66% | ||
| ROE | 9.57% | ||
| ROCE | 9.13% | ||
| ROIC | 6.52% | ||
| ROICexc | 6.77% | ||
| ROICexgc | 14.86% | ||
| OM | 9.37% | ||
| PM (TTM) | 4.62% | ||
| GM | 44.9% | ||
| FCFM | 0.47% |
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
ROICexc(3y)4.63%
ROICexc(5y)4.13%
ROICexgc(3y)10.78%
ROICexgc(5y)9.37%
ROCE(3y)6.5%
ROCE(5y)5.8%
ROICexgc growth 3Y7.97%
ROICexgc growth 5Y2.8%
ROICexc growth 3Y6.71%
ROICexc growth 5Y0.74%
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
F-Score5
Asset Turnover0.79
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 70.49 | ||
| Debt/EBITDA | 2.47 | ||
| Cap/Depr | 94.13% | ||
| Cap/Sales | 3.57% | ||
| Interest Coverage | 6.62 | ||
| Cash Conversion | 30.7% | ||
| Profit Quality | 10.18% | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 1.97 |
F-Score5
WACC6.58%
ROIC/WACC0.99
Cap/Depr(3y)82.25%
Cap/Depr(5y)102.09%
Cap/Sales(3y)4.73%
Cap/Sales(5y)5.79%
Profit Quality(3y)118.21%
Profit Quality(5y)101.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
EBIT growth 1Y-8.88%
EBIT growth 3Y18.26%
EBIT growth 5Y14.91%
EBIT Next Year68.09%
EBIT Next 3Y22.98%
EBIT Next 5Y16.09%
FCF growth 1Y-88.34%
FCF growth 3Y4.79%
FCF growth 5Y6.69%
OCF growth 1Y-35.2%
OCF growth 3Y-1.23%
OCF growth 5Y13.09%
GAROFALO HEALTH CARE SPA / GHC.MI FAQ
What is the ChartMill fundamental rating of GAROFALO HEALTH CARE SPA (GHC.MI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to GHC.MI.
What is the valuation status for GHC stock?
ChartMill assigns a valuation rating of 4 / 10 to GAROFALO HEALTH CARE SPA (GHC.MI). This can be considered as Fairly Valued.
How profitable is GAROFALO HEALTH CARE SPA (GHC.MI) stock?
GAROFALO HEALTH CARE SPA (GHC.MI) has a profitability rating of 6 / 10.
What is the financial health of GAROFALO HEALTH CARE SPA (GHC.MI) stock?
The financial health rating of GAROFALO HEALTH CARE SPA (GHC.MI) is 4 / 10.
What is the expected EPS growth for GAROFALO HEALTH CARE SPA (GHC.MI) stock?
The Earnings per Share (EPS) of GAROFALO HEALTH CARE SPA (GHC.MI) is expected to grow by 3.45% in the next year.